Related Experiment Video
Updated: Jun 23, 2026
11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms
Annals of Internal Medicine
|April 1, 1976
Summary
In patients with both insulin and aldosterone deficiency, high blood sugar paradoxically raises potassium levels. Managing hyperglycemia is crucial to prevent dangerous hyperkalemia in these individuals.
Area of Science:
- Endocrinology
- Metabolic disorders
- Renal physiology
Background:
- Isolated hyporeninemic hypoaldosteronism is a condition characterized by aldosterone deficiency.
- Insulin deficiency, as seen in diabetes mellitus, affects glucose metabolism and electrolyte balance.
- Combined insulin and aldosterone deficiency presents unique challenges in maintaining homeostasis.
Purpose of the Study:
- To investigate the effect of acute glucose infusion on serum potassium levels in patients with combined insulin and aldosterone deficiency.
- To compare the potassium response to glucose in patients with combined deficiency versus those with isolated deficiencies or normal controls.
- To elucidate the roles of insulin and aldosterone in potassium regulation during hyperglycemia.
Main Methods:
- Studied two patients with insulin-requiring diabetes and isolated hyporeninemic hypoaldosteronism.
- Administered acute glucose infusions to assess serum potassium changes.
- Investigated the effects of desoxycorticosterone acetate and insulin administration prior to glucose infusion.
Main Results:
- Hyperglycemia aggravated hyperkalemia in patients with combined insulin and aldosterone deficiency.
- Acute glucose infusions raised serum potassium in these patients, unlike in normal subjects or those with single hormone deficiencies.
- Desoxycorticosterone acetate partially blunted the hyperkalemic response, while insulin abolished it.
Conclusions:
- Insulin and aldosterone play critical roles in regulating serum potassium in humans.
- Hyperglycemia can precipitate dangerous hyperkalemia in individuals with combined insulin and aldosterone deficiency.
- Avoiding hyperglycemia is essential for managing patients with this dual hormonal deficiency.
Related Concept Videos
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:25Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...